Company Announcements

25 November 2022

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

Notice of Q4 and Full Year Results

Webcast for analysts and institutional investors

Equity Development webcast for retail investors

Benchmark Holdings plc (AIM: BMK), the aquaculture biotechnology business, will announce its Q4 and Full Year results, for the three and 12 month periods ended 30 September 2022, on Wednesday 30^th November 2022. 

Webcast for analysts and institutional investors at 9am UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on the day at 09:00am UK time. To register your interest, please contact benchmark@mhpgroup.com.

Equity Development webcast for retail investors at 12:00pm UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a separate webcast for retail investors and wealth managers at 12.00pm UK time. The webcast is open to all existing and potential shareholders. Questions can be submitted during the presentation which will be addressed at the end.

To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-fyresults-presentation-30nov2022

  Enquiries

About Benchmark

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology to develop innovative products and solutions which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), specialist diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com.